RBC Europe’s Edwards Lifesciences EW Stock Holding History

RBC Europe’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$588K	Hold	6,181	–	–	0.03%	132
2022 Q1	$728K	Sell	6,181 -20	-0.3%	-$2.24K	0.03%	128
2021 Q4	$803K	Buy	6,201 +420	+7%	+$49K	0.04%	123
2021 Q3	$654K	Buy	5,781 +60	+1%	+$6.85K	0.03%	174
2021 Q2	$593K	Buy	5,721 +2,070	+57%	+$195K	0.03%	187
2021 Q1	$305K	Hold	3,651	–	–	0.02%	235
2020 Q4	$333K	Hold	3,651	–	–	0.02%	215
2020 Q3	$291K	Sell	3,651 -300	-8%	-$23.4K	0.02%	214
2020 Q2	$273K	Buy	3,951 +1,290	+48%	+$91.7K	0.02%	212
2020 Q1	$167K	Sell	2,661 -270	-9%	-$19.5K	0.02%	232
2019 Q4	$228K	Hold	2,931	–	–	0.02%	235
2019 Q3	$215K	Sell	2,931 -210	-7%	-$14.8K	0.02%	238
2019 Q2	$193K	Buy	3,141 +225	+8%	+$13.6K	0.02%	250
2019 Q1	$186K	Sell	2,916 -318	-10%	-$18.1K	0.02%	245
2018 Q4	$165K	Hold	3,234	–	–	0.02%	243
2018 Q3	$188K	Hold	3,234	–	–	0.02%	257
2018 Q2	$157K	Hold	3,234	–	–	0.02%	285
2018 Q1	$150K	Hold	3,234	–	–	0.02%	277
2017 Q4	$122K	Hold	3,234	–	–	0.02%	325
2017 Q3	$118K	Buy	+3,234	New	+$123K	0.02%	328

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RBC Europe's EW Position: Q2 2022 in Review

RBC Europe held its Edwards Lifesciences (EW) position steady in Q2 2022 at 6,181 shares worth $588K. The position accounts for 0.03% of the portfolio, ranked #132.

RBC Europe first reported a position in EW in Q3 2017 and has held it in 20 quarters since. The position peaked at $803K in Q4 2021. 1,273 funds tracked by Wall St. Rank hold EW as of Q2 2022.

RBC Europe held 6,181 shares of Edwards Lifesciences worth $588K as of Q2 2022.
RBC Europe left its Edwards Lifesciences share count unchanged in Q2 2022.
Edwards Lifesciences made up 0.03% of RBC Europe's portfolio in Q2 2022, its #132 holding.
RBC Europe first reported a position in Edwards Lifesciences in Q3 2017 and has held it in 20 quarters since.
RBC Europe's Edwards Lifesciences position peaked at $803K in Q4 2021.
1,273 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.